Factors Affecting the Prognosis of Early Ovarian Cancer

Sponsor
Far Eastern Memorial Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04414683
Collaborator
(none)
300
1
56.6
5.3

Study Details

Study Description

Brief Summary

To elucidate factors affecting survival of early stage ovarian cancer

Condition or Disease Intervention/Treatment Phase
  • Procedure: staging surgery

Detailed Description

To analyze factors affecting survival of early ovarian cancer, such as cell type, cell grade, intraoperative rupture, and laparoscopy vs. laparotomy, etc.

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Factors Affecting the Prognosis of Early Ovarian Cancer
Actual Study Start Date :
Apr 13, 2020
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Outcome Measures

Primary Outcome Measures

  1. Factors affecting overall survival of early ovarian cancer [10 years]

Secondary Outcome Measures

  1. Factors affecting progression-free survival of early ovarian cancer [10 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • early stage ovarian cancer
Exclusion Criteria:
  • Nil.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital Banqiao New Taipei Taiwan 22050

Sponsors and Collaborators

  • Far Eastern Memorial Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sheng-Mou Hsiao, Chief of Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT04414683
Other Study ID Numbers:
  • 109058-E
First Posted:
Jun 4, 2020
Last Update Posted:
Feb 8, 2022
Last Verified:
Jun 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2022